TY - JOUR
T1 - EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids
T2 - A systematic review and meta-analysis
AU - Grützmeier, Simon Ezban
AU - Sodal, Hafsa Mahad Mahamud
AU - Kovacevic, Bojan
AU - Vilmann, Peter
AU - Karstensen, John Gásdal
AU - Klausen, Pia
N1 - Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
PY - 2024/10
Y1 - 2024/10
N2 - BACKGROUND AND AIMS: Patient-derived tumor organoids (PDTOs) are a promising new disease model in pancreatic cancer for use in personalized medicine. However, the overall success rate (SR) of establishing these cultures from EUS-guided biopsies is unknown.METHODS: We searched relevant database publications reporting SRs of PDTO establishment from pancreatic cancer. The primary outcome was SR stratified on tissue acquisition method (EUS-guided biopsies, percutaneous biopsies, and surgical specimens).RESULTS: Twenty-four studies were identified that included 1053 attempts at establishing PDTOs. Overall SR was 63% (95% confidence interval [CI], 54%-72%). Pooled SRs of PDTO establishment from EUS-guided biopsies, percutaneous biopsies, and surgical specimens were 60% (95% CI, 43%-76%), 36% (95% CI, 14%-61%), and 62% (95% CI, 48%-75%), respectively, and did not differ significantly (P = .1975).CONCLUSION: The SR of PDTO establishment from EUS-guided biopsies is comparable to that from surgical specimens. Both techniques are suitable for tissue acquisition for PDTOs in clinical and research settings. (PROSPERO registration number: CRD42023425121.).
AB - BACKGROUND AND AIMS: Patient-derived tumor organoids (PDTOs) are a promising new disease model in pancreatic cancer for use in personalized medicine. However, the overall success rate (SR) of establishing these cultures from EUS-guided biopsies is unknown.METHODS: We searched relevant database publications reporting SRs of PDTO establishment from pancreatic cancer. The primary outcome was SR stratified on tissue acquisition method (EUS-guided biopsies, percutaneous biopsies, and surgical specimens).RESULTS: Twenty-four studies were identified that included 1053 attempts at establishing PDTOs. Overall SR was 63% (95% confidence interval [CI], 54%-72%). Pooled SRs of PDTO establishment from EUS-guided biopsies, percutaneous biopsies, and surgical specimens were 60% (95% CI, 43%-76%), 36% (95% CI, 14%-61%), and 62% (95% CI, 48%-75%), respectively, and did not differ significantly (P = .1975).CONCLUSION: The SR of PDTO establishment from EUS-guided biopsies is comparable to that from surgical specimens. Both techniques are suitable for tissue acquisition for PDTOs in clinical and research settings. (PROSPERO registration number: CRD42023425121.).
KW - Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods
KW - Endosonography/methods
KW - Humans
KW - Image-Guided Biopsy/methods
KW - Organoids/pathology
KW - Pancreatic Neoplasms/pathology
KW - Ultrasonography, Interventional/methods
UR - http://www.scopus.com/inward/record.url?scp=85199684618&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2024.04.012
DO - 10.1016/j.gie.2024.04.012
M3 - Review
C2 - 38593932
SN - 0016-5107
VL - 100
SP - 750
EP - 755
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 4
ER -